TET2 Mutations Are Associated with Specific 5-Methylcytosine and 5-Hydroxymethylcytosine Profiles in Patients with Chronic Myelomonocytic Leukemia

• Cristina Pérez,

  Affiliation Laboratory of Myeloproliferative Syndromes, Oncology Area, University of Navarra, Pamplona, Spain

  ⨯
• Nicolas Martínez-Calle,

  Affiliation Laboratory of Myeloproliferative Syndromes, Oncology Area, University of Navarra, Pamplona, Spain

  ⨯
• José Ignacio Martín-Subero,

  Affiliation Department of Anatomic Pathology, Pharmacology and Microbiology, University of Barcelona, Barcelona, Spain

  ⨯
• Victor Segura,

  Affiliation Department of Bioinformatics, Foundation for Applied Medical Research, University of Navarra, Pamplona, Spain

  ⨯
• Eric Delabesse,

  Affiliation CHU Toulouse, Laboratoire d'Hematologie, Hôpital Purpan, Inserm U1037, University Paul Sabatier, Toulouse, France

  ⨯
• Marta Fernandez-Mercado,

  Affiliation LLR Molecular Haematology Unit, NDCLS, John Radcliffe Hospital, Oxford, United Kingdom

  ⨯
• Leire Garate,

  Affiliation Laboratory of Myeloproliferative Syndromes, Oncology Area, University of Navarra, Pamplona, Spain

  ⨯
• Sara Alvarez,

  Affiliation Molecular Cytogenetics Group, Centro Nacional Investigaciones Oncológicas (CNIO), Madrid, Spain

  ⨯
• José Rifon,

  Affiliation Hematology Service and Area of Cell Therapy, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain

  ⨯
• Sara Varea,

  Affiliation Hematology Service and Area of Cell Therapy, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain

  ⨯
• Jacqueline Boultwood,

  Affiliation LLR Molecular Haematology Unit, NDCLS, John Radcliffe Hospital, Oxford, United Kingdom

  ⨯
• James S. Wainscoat,

  Affiliation LLR Molecular Haematology Unit, NDCLS, John Radcliffe Hospital, Oxford, United Kingdom

  ⨯
• Juan Cruz Cigudosa,

  Affiliation Molecular Cytogenetics Group, Centro Nacional Investigaciones Oncológicas (CNIO), Madrid, Spain

  ⨯
• María José Calasanz,

  Affiliation Department of Genetics, University of Navarra, Pamplona, Spain

  ⨯
• Nicholas C. P. Cross,

  Affiliations Wessex Regional Genetics Laboratory, Salisbury, United Kingdom, Faculty of Medicine, University of Southampton, Southampton, United Kingdom

  ⨯
• Felipe Prósper ,

  Contributed equally to this work with: Felipe Prósper, Xabier Agirre

  * E-mail: fprosper@unav.es (FP); xaguirre@unav.es (XA)

  Affiliations Laboratory of Myeloproliferative Syndromes, Oncology Area, University of Navarra, Pamplona, Spain, Hematology Service and Area of Cell Therapy, Clínica Universidad de Navarra, University of Navarra, Pamplona, Spain

  ⨯
•  [ ... ],
• Xabier Agirre

  Contributed equally to this work with: Felipe Prósper, Xabier Agirre

  * E-mail: fprosper@unav.es (FP); xaguirre@unav.es (XA)

  Affiliation Laboratory of Myeloproliferative Syndromes, Oncology Area, University of Navarra, Pamplona, Spain

  ⨯
• [ view all ]
• [ view less ]